These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8964913)

  • 1. A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis.
    van Oosten BW; Rep MH; van Lier RA; Scholten PE; von Blomberg BM; Pflughaupt KW; Hartung HP; Adèr HJ; Polman CH
    J Neuroimmunol; 1996 May; 66(1-2):49-55. PubMed ID: 8964913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis.
    Rieckmann P; Weber F; Günther A; Martin S; Bitsch A; Broocks A; Kitze B; Weber T; Börner T; Poser S
    J Neuroimmunol; 1996 Feb; 64(2):193-200. PubMed ID: 8632062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase.
    Myers LW; Ellison GW; Merrill JE; El Hajjar A; St Pierre B; Hijazin M; Leake BD; Bentson JR; Nuwer MR; Tourtellotte WW; Davis P; Granger D; Fahey JL
    Neurology; 1998 Nov; 51(5):1483-6. PubMed ID: 9818891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pentoxifylline: is it useful in multiple sclerosis?].
    Prieto JM; Dapena D; Lema M; Ares B; Cacabelos P; Noya M
    Rev Neurol; 2001 Mar 16-31; 32(6):529-31. PubMed ID: 11353990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis.
    Baraczka K; Pozsonyi T; Szüts I; Ormos G; Nékám K
    Acta Microbiol Immunol Hung; 2003; 50(4):339-48. PubMed ID: 14750436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
    Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of pentoxifylline in multiple sclerosis.
    Friedman JE; Zabriskie J; Bourganskaia E
    Arch Neurol; 1996 Oct; 53(10):956-7. PubMed ID: 8859054
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.
    Fujimoto T; Nakamura T; Furuya T; Nakane S; Shirabe S; Kambara C; Hamasaki S; Yoshimura T; Eguchi K
    Intern Med; 1999 Sep; 38(9):717-21. PubMed ID: 10480302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis].
    Smagina IV; El'chaninova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):43-6. PubMed ID: 24300814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis.
    Bharucha AE; Jorgensen R; Lichtman SN; LaRusso NF; Lindor KD
    Am J Gastroenterol; 2000 Sep; 95(9):2338-42. PubMed ID: 11007239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
    Jensen J; Krakauer M; Sellebjerg F
    Cytokine; 2005 Jan; 29(1):24-30. PubMed ID: 15579375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis.
    Chofflon M; Juillard C; Juillard P; Gauthier G; Grau GE
    Eur Cytokine Netw; 1992; 3(6):523-31. PubMed ID: 1296800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.
    Brucklacher-Waldert V; Stuerner K; Kolster M; Wolthausen J; Tolosa E
    Brain; 2009 Dec; 132(Pt 12):3329-41. PubMed ID: 19933767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules.
    Noel C; Copin MC; Hazzan M; Labalette M; Susen S; Lelievre G; Dessaint JP
    Transplantation; 2000 Mar; 69(6):1102-7. PubMed ID: 10762214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix.
    Shirin H; Bruck R; Aeed H; Frenkel D; Kenet G; Zaidel L; Avni Y; Halpern Z; Hershkoviz R
    J Hepatol; 1998 Jul; 29(1):60-7. PubMed ID: 9696493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
    Schimrigk S; Brune N; Hellwig K; Lukas C; Bellenberg B; Rieks M; Hoffmann V; Pöhlau D; Przuntek H
    Eur J Neurol; 2006 Jun; 13(6):604-10. PubMed ID: 16796584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline Treatment in Severe Acute Pancreatitis: A Pilot, Double-Blind, Placebo-Controlled, Randomized Trial.
    Vege SS; Atwal T; Bi Y; Chari ST; Clemens MA; Enders FT
    Gastroenterology; 2015 Aug; 149(2):318-20.e3. PubMed ID: 26112745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study.
    Landman D; Sarai A; Sathe SS
    Clin Infect Dis; 1994 Jan; 18(1):97-9. PubMed ID: 8054441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.